Mechanisms for the therapeutic effect of fenofibrate on diabetic retinopathy and its clinical application
10.3760/cma.j.issn.1005-1015.2017.02.026
- VernacularTitle:非诺贝特治疗糖尿病视网膜病变的机制及其临床应用研究现状
- Author:
Ying LIU
;
Ximei DUAN
;
Jixiong XU
- Keywords:
Diabetic retinopathy/drug therapy;
Fenofibrate/therapeutic use;
Review
- From:
Chinese Journal of Ocular Fundus Diseases
2017;33(2):206-209
- CountryChina
- Language:Chinese
-
Abstract:
Chronic inflammation,oxidative stress and retinal ganglion cell apoptosis play important roles in the development of diabetic retinopathy.Fenofibrate,a peroxisome proliferator-activated receptor α agonist,is used for dyslipidemia.In addition to its lipid-modulating effects,fenofibrate also has antiinflammatory,antioxidant,anti-apoptotic and anti-angiogenesis properties that may be useful to delay the progression of diabetic retinopathy.Some clinical studies have already confirmed that fenofibrate has therapeutic effect on diabetic retinopathy.Further studies the application of fenofibrate in the treatment of diabetic microangiopathy to clarify the safety and efficacy of fenofibrate is of great significance.
